Implementation outcome measure | Description | Framework used | Participant type |
---|---|---|---|
1.  Acceptability | Acceptability is the perception of patients and clinic staff that LAI CAB/RPV treatment is agreeable, relevant, suitable, and satisfactory. | PROCTOR | PLWH |
2.  Reacha | Reach is the extent to which LAI CAB/RPV is received by its target group. Qualitatively, the reach dimension involves understanding why people accept or decline participation. Are we reaching those who would benefit most from LAI CAB/RPV treatment? | RE-AIM | PLWH, physicians |
3.  Effectivenessa | Effectiveness is the influence or impact of LAI CAB/RPV on important patient outcomes, including potential negative effects, quality of life, & economic outcomes. | RE-AIM | PLWH, physicians, clinic staff |
4.  Adoptiona | Adoption refers to understanding why different clinic staff/key agents within an organization choose to adopt LAI CAB/RPV or not in general practices, namely facilitators and barriers. | RE-AIM | Physicians, clinic staff |
5.  Implementationa | Implementation refers to the extent to which LAI CAB/RPV was delivered with fidelity and to understanding adaptations made to deliver injectable treatment, implementation strategies used, and cost. | RE-AIM | Physicians, clinic staff |
6.  Maintenancea | Maintenance explores sustainability problems, i.e., reasons why patients/clinic staff may continue or discontinue LAI CAB/RPV use or delivery in the long term. | RE-AIM | PLWH, physicians, clinic staff |